Home›Companies›Healthcare›mPharma Data

mPharma Data, Inc

Updated Oct 27, 2026·Latest SEC filing Jan 30, 2024·Suggest an edit

About mPharma Data

mPharma Data is a private company based in Lexington, Massachusetts. It has reported $46,920,740 raised in four offerings on Form D since January 2016. Its chief executive is Gregory Rockson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 26, 2023Jan 30, 2024$13,669,861fully sold22$621KEquityRule 506(b)Form D ↗
Jan 21, 2020Jan 31, 2020amended Apr 13, 2020$18,521,879of $21.5M target17$1.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Dec 31, 2018Jan 10, 2019$9,729,000of $12.0M target18$540KEquityRule 506(b)Form D ↗
Dec 21, 2015Jan 28, 2016$5,000,000fully sold14$357KEquityRule 506(b)Form D ↗
Total, four offerings$46,920,740

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on mPharma Data's Form D filed Jan 30, 2024.

DS
Daniel Shoukimas
Executive officer
GR
Gregory Rockson
CEO and director
PS
Philip Sowah
Director
SM

Earlier filings also listed Walter Baddoo (director, last listed Apr 2020), Sophia Baah (executive officer, last listed Apr 2020), Sangu Delle (director, last listed Apr 2020), Nana Addo (executive officer, last listed Apr 2020), James Finucane (executive officer, last listed Apr 2020), Daniel Vasella (director, last listed Apr 2020), Andrew Carruthers (director, last listed Apr 2020) and Dufie Addo (executive officer, last listed Jan 2019).

Sources

  1. SECmPharma Data, Inc Form D, filed Jan 31, 2020
  2. SECmPharma Data, Inc filing history